Pharmacological unmasking microarray approach-based discovery of novel DNA methylation markers for hepatocellular carcinoma

Namhee Jung, Jae Kyung Won, Baek-Hui Kim, Kyung Suk Suh, Ja June Jang, Gyeong Hoon Kang

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

DNA methylation is one of the main epigenetic mechanisms and hypermethylation of CpG islands at tumor suppressor genes switches off these genes. To find novel DNA methylation markers in hepatocellular carcinoma (HCC), we performed pharmacological unmasking (treatment with 5-aza-2'-deoxycytidine or trichostatin A) followed by microarray analysis in HCC cell lines. Of the 239 promoter CpG island loci hypermethylated in HCC cell lines (as revealed by methylation-specific PCR), 221 loci were found to be hypermethylated in HCC or nonneoplastic liver tissues. Thirty-three loci showed a 20% higher methylation frequency in tumors than in adjacent nonneoplastic tissues. Correlation of individual cancer-related methylation markers with clinicopathological features of HCC patients (n=95) revealed that the number of hypermethylated genes in HCC tumors was higher in older than in younger patients. Univariate and multivariate survival analysis revealed that the HIST1H2AE methylation status is closely correlated with the patient's overall survival (P=0.022 and P=0.010, respectively). In conclusion, we identified 221 novel DNA methylation markers for HCC. One promising prognostic marker, HIST1H2AE, should be further validated in the prognostication of HCC patients.

Original languageEnglish
Pages (from-to)594-604
Number of pages11
JournalJournal of Korean Medical Science
Volume27
Issue number6
DOIs
Publication statusPublished - 2012 Jun 1
Externally publishedYes

Fingerprint

DNA Methylation
Genetic Markers
Hepatocellular Carcinoma
Pharmacology
Methylation
CpG Islands
decitabine
trichostatin A
Switch Genes
Cell Line
Neoplasms
Microarray Analysis
Survival Analysis
Tumor Suppressor Genes
Epigenomics
Multivariate Analysis
Polymerase Chain Reaction
Survival
Liver
Genes

Keywords

  • Carcinoma
  • CpG islands
  • DNA methylation
  • Hepatocellular
  • Microarray
  • Prognosis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pharmacological unmasking microarray approach-based discovery of novel DNA methylation markers for hepatocellular carcinoma. / Jung, Namhee; Won, Jae Kyung; Kim, Baek-Hui; Suh, Kyung Suk; Jang, Ja June; Kang, Gyeong Hoon.

In: Journal of Korean Medical Science, Vol. 27, No. 6, 01.06.2012, p. 594-604.

Research output: Contribution to journalArticle

Jung, Namhee ; Won, Jae Kyung ; Kim, Baek-Hui ; Suh, Kyung Suk ; Jang, Ja June ; Kang, Gyeong Hoon. / Pharmacological unmasking microarray approach-based discovery of novel DNA methylation markers for hepatocellular carcinoma. In: Journal of Korean Medical Science. 2012 ; Vol. 27, No. 6. pp. 594-604.
@article{0f8512ce366d428a9a72a799e201ad32,
title = "Pharmacological unmasking microarray approach-based discovery of novel DNA methylation markers for hepatocellular carcinoma",
abstract = "DNA methylation is one of the main epigenetic mechanisms and hypermethylation of CpG islands at tumor suppressor genes switches off these genes. To find novel DNA methylation markers in hepatocellular carcinoma (HCC), we performed pharmacological unmasking (treatment with 5-aza-2'-deoxycytidine or trichostatin A) followed by microarray analysis in HCC cell lines. Of the 239 promoter CpG island loci hypermethylated in HCC cell lines (as revealed by methylation-specific PCR), 221 loci were found to be hypermethylated in HCC or nonneoplastic liver tissues. Thirty-three loci showed a 20{\%} higher methylation frequency in tumors than in adjacent nonneoplastic tissues. Correlation of individual cancer-related methylation markers with clinicopathological features of HCC patients (n=95) revealed that the number of hypermethylated genes in HCC tumors was higher in older than in younger patients. Univariate and multivariate survival analysis revealed that the HIST1H2AE methylation status is closely correlated with the patient's overall survival (P=0.022 and P=0.010, respectively). In conclusion, we identified 221 novel DNA methylation markers for HCC. One promising prognostic marker, HIST1H2AE, should be further validated in the prognostication of HCC patients.",
keywords = "Carcinoma, CpG islands, DNA methylation, Hepatocellular, Microarray, Prognosis",
author = "Namhee Jung and Won, {Jae Kyung} and Baek-Hui Kim and Suh, {Kyung Suk} and Jang, {Ja June} and Kang, {Gyeong Hoon}",
year = "2012",
month = "6",
day = "1",
doi = "10.3346/jkms.2012.27.6.594",
language = "English",
volume = "27",
pages = "594--604",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "6",

}

TY - JOUR

T1 - Pharmacological unmasking microarray approach-based discovery of novel DNA methylation markers for hepatocellular carcinoma

AU - Jung, Namhee

AU - Won, Jae Kyung

AU - Kim, Baek-Hui

AU - Suh, Kyung Suk

AU - Jang, Ja June

AU - Kang, Gyeong Hoon

PY - 2012/6/1

Y1 - 2012/6/1

N2 - DNA methylation is one of the main epigenetic mechanisms and hypermethylation of CpG islands at tumor suppressor genes switches off these genes. To find novel DNA methylation markers in hepatocellular carcinoma (HCC), we performed pharmacological unmasking (treatment with 5-aza-2'-deoxycytidine or trichostatin A) followed by microarray analysis in HCC cell lines. Of the 239 promoter CpG island loci hypermethylated in HCC cell lines (as revealed by methylation-specific PCR), 221 loci were found to be hypermethylated in HCC or nonneoplastic liver tissues. Thirty-three loci showed a 20% higher methylation frequency in tumors than in adjacent nonneoplastic tissues. Correlation of individual cancer-related methylation markers with clinicopathological features of HCC patients (n=95) revealed that the number of hypermethylated genes in HCC tumors was higher in older than in younger patients. Univariate and multivariate survival analysis revealed that the HIST1H2AE methylation status is closely correlated with the patient's overall survival (P=0.022 and P=0.010, respectively). In conclusion, we identified 221 novel DNA methylation markers for HCC. One promising prognostic marker, HIST1H2AE, should be further validated in the prognostication of HCC patients.

AB - DNA methylation is one of the main epigenetic mechanisms and hypermethylation of CpG islands at tumor suppressor genes switches off these genes. To find novel DNA methylation markers in hepatocellular carcinoma (HCC), we performed pharmacological unmasking (treatment with 5-aza-2'-deoxycytidine or trichostatin A) followed by microarray analysis in HCC cell lines. Of the 239 promoter CpG island loci hypermethylated in HCC cell lines (as revealed by methylation-specific PCR), 221 loci were found to be hypermethylated in HCC or nonneoplastic liver tissues. Thirty-three loci showed a 20% higher methylation frequency in tumors than in adjacent nonneoplastic tissues. Correlation of individual cancer-related methylation markers with clinicopathological features of HCC patients (n=95) revealed that the number of hypermethylated genes in HCC tumors was higher in older than in younger patients. Univariate and multivariate survival analysis revealed that the HIST1H2AE methylation status is closely correlated with the patient's overall survival (P=0.022 and P=0.010, respectively). In conclusion, we identified 221 novel DNA methylation markers for HCC. One promising prognostic marker, HIST1H2AE, should be further validated in the prognostication of HCC patients.

KW - Carcinoma

KW - CpG islands

KW - DNA methylation

KW - Hepatocellular

KW - Microarray

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=84866459948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866459948&partnerID=8YFLogxK

U2 - 10.3346/jkms.2012.27.6.594

DO - 10.3346/jkms.2012.27.6.594

M3 - Article

VL - 27

SP - 594

EP - 604

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 6

ER -